摘要
本文界定了患者药品福利的含义,将消费者剩余理论作为量化分析工具,分析药品价格、药品可及性以及医生诱导需求对患者药品福利的影响。结果显示:药品价格降低、可及性提高和医生诱导需求减少,都会在一定程度上增加患者药品福利。因此,为提升患者药品福利,建议"零关税、进医保、促仿制"多措并举、发挥政府与制药企业的协同作用、防范医生诱导需求。
This paper defined the meaning of patient drug welfare,and used the theory of consumer surplus as a quantitative analysis tool to analyze the impact of drug price,drug accessibility and doctor-induced demand on patient drug welfare. The results showed that lower drug prices,improved accessibility,and reduced doctor-induced demand will increase patient drug benefits to some extent. Therefore,in order to improve the patient's drug welfare,it is recommended that "zero tariff,medical insurance,and imitation system" measures to play a synergistic role between the government and pharmaceutical companies to prevent doctor-induced demand.
引文
[1]邵蓉,王梦媛,颜建周,等.我国网售处方药报销面临的问题及对策分析——基于美国药品福利管理模式[J].中国卫生政策研究,2016,9(4):31-36.
[2]丁锦希,黄泽华,钭江苑.澳大利亚专利药价格谈判制度实证研究与启示[J].中国卫生经济,2016,35(12):116-119.
[3]施雯,宋德群,周艳波.农户福利研究述评[J].农业经济,2015(9):113-114.
[4]马旭东,史岩.福利经济学:缘起、发展与解构[J].经济问题,2018(2):9-16.
[5]姚进忠.福利研究新视角:可行能力的理论起点、内涵与演进[J].国外社会学,2018(2):53-67.
[6] Thijs ten Raa. Homothetic utility, Roy’s Lemma and consumer’s surplus[J]. Economics Letters,2017,161(C):1-164.
[7]戚昌厚,柏明远.序数效用需求曲线不兼容消费者剩余[J].中国物价,2018(3):36-39,51.
[8]张晓燕,袁萍.我国公立医院医生诱导需求的防范与规制研究——基于激励规制理论的视角[J].中国卫生事业管理,2016,33(9):664-666.